Terns Pharmaceuticals, Inc. (TERN) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Cash from Operations | -19.08M | -19.77M | -18.88M | -24.45M | -14.58M | -16.45M | -16.18M | -22.8M | -19.32M | -20.7M | -12.99M | -14.38M | -11.21M | -13.58M | -11.16M | -13.3M | -13.39M | -8.08M | -8.76M | -14.32M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1339% | - | - | - |
| Operating CF Growth % | -30.85% | -20.16% | -16.69% | -7.23% | 24.5% | 20.5% | -24.52% | -58.52% | -72.3% | -52.42% | -16.4% | -8.14% | 16.27% | -68.03% | -27.42% | 7.1% | -81.26% | -28.02% | - | -96.46% |
| Net Income | -23.57M | -24.64M | -24.09M | -23.91M | -21.8M | -21.95M | -22.74M | -22.37M | -21.02M | -29.77M | -17.9M | -21.53M | -15.82M | -16.82M | -13.93M | -13.77M | -14.25M | -11.84M | -10.74M | -13.34M |
| Depreciation & Amortization | 113K | 111K | 108K | 169K | 214K | 206K | 240K | 236K | 220K | 222K | 217K | 222K | 233K | 252K | 269K | 278K | 114K | 107K | 119K | 172K |
| Stock-Based Compensation | 3.35M | 3.34M | 3.03M | 0 | 3.02M | 4.16M | 4.42M | 4.03M | 3.28M | 14.08M | 4.23M | 3.94M | 2.69M | 0 | 2.65M | 2.74M | 0 | 1.85M | 1.91M | 1.83M |
| Deferred Taxes | 0 | 34K | 0 | 34K | -79K | -68K | 34K | 34K | 45K | 0 | 32K | 32K | 353K | 14K | 4K | 21K | 174K | 7K | 22K | 16K |
| Other Non-Cash Items | 475K | 11K | 8K | 3.56M | -1.16M | -741K | -607K | -915K | -1.5M | -3.93M | -975K | -806K | -566K | 2.52M | 60K | 613K | 23K | 535K | 153K | -3K |
| Working Capital Changes | 548K | 1.36M | 2.07M | -4.3M | 5.22M | 1.94M | 2.47M | -3.81M | -345K | -1.31M | 1.4M | 3.76M | 1.9M | 458K | -216K | -3.18M | 547K | 1.25M | -225K | -3M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.31M | 97K | 71K | 630K | 415K | -140K | 172K | -814K | -810K | 0 | 2.85M | 1.32M | -471K | 864K | -705K | -410K | 506K | -106K | -881K | 2.21M |
| Cash from Investing | -350M | 24.5M | 25.5M | 1.96M | -94.35M | 31.75M | 42.19M | 8M | 47.23M | -22.31M | -90.84M | 27.93M | -14.55M | -1.24M | -15.97M | 9.49M | -6.42M | 4.44M | -20.9M | -96.82M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -13K | -29K | -44K | -8K | 0 | 0 | -34K | 8K | -7K | -242K | -200K | -74K | -42K | -24K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -47.28K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47.28K | -22.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 743.12M | 0 | 324K | 74K | 304K | 163.29M | 399K | 0 | 13.86M | 20K | 489K | 27.58M | 105.97M | 61.15M | 124K | 0 | 2.74M | 797K | -1.59M | 135.17M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.88M |
| Equity Issued (Net) | 743.35M | 0 | 318K | 74K | 0 | 162.31M | 0 | 0 | 13.69M | 0 | 489K | 27.92M | 106.11M | 61.15M | 124K | 0 | 2.74M | 0 | -1.59M | 136.36M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -229K | 0 | 6K | 0 | 304K | 980K | 399K | 0 | 175K | 20K | 0 | -344K | -138K | 0 | 0 | 0 | 0 | 797K | 0 | 11.69M |
| Net Change in Cash | 374.05M | 4.73M | 6.94M | -22.42M | -108.7M | 178.64M | 26.4M | -14.83M | 42.03M | -43.03M | -103.44M | 41.12M | 80.26M | 46.17M | -27.07M | -3.82M | -17.05M | -2.84M | -31.24M | 23.98M |
| Free Cash Flow | -19.08M | -19.77M | -18.88M | -24.45M | -14.58M | -16.45M | -16.19M | -22.83M | -19.36M | -20.71M | -12.99M | -14.38M | -11.24M | -13.57M | -11.17M | -13.54M | -13.59M | -8.16M | -8.8M | -14.34M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1359% | - | - | - |
| FCF Growth % | -30.85% | -20.16% | -16.6% | -7.09% | 24.67% | 20.53% | -24.62% | -58.72% | -72.17% | -52.57% | -16.33% | -6.2% | 17.26% | -66.41% | -26.89% | 5.56% | -82.81% | -29.09% | - | -85.82% |
| FCF per Share | -0.20 | -0.22 | -0.21 | -0.27 | -0.16 | -0.21 | -0.22 | -0.31 | -0.27 | -0.29 | -0.18 | -0.21 | -0.21 | -0.35 | -0.44 | -0.54 | -0.54 | -0.32 | -0.35 | -0.57 |
| FCF Conversion (FCF/Net Income) | 0.81x | 0.80x | 0.78x | 1.02x | 0.67x | 0.75x | 0.71x | 1.02x | 0.92x | 0.70x | 0.73x | 0.67x | 0.71x | 0.81x | 0.80x | 0.97x | 0.94x | 0.68x | 0.82x | 1.07x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |